Details of the Drug

General Information of Drug (ID: DM5T6BM)

Drug Name

Atuzaginstat

Synonyms

Atuzaginstat; DGN7ROZ8EN; Atuzaginstat [INN]; UNII-DGN7ROZ8EN; 2211981-76-7; COR388; COR-388; Cyclopentanecarboxamide, N-((1S)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)-; N-((3S)-7-Amino-2-oxo-1-(2,3,6- trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide; AtuzaginstatCOR388; CHEMBL5095230; SCHEMBL19972758; BDBM453275; EX-A6081; US10730826, Compound 1a-racemic; US10730826, Compound 1a-non-racemic; N-[(3S)-7-amino-2-oxo-1-(2,3,6-trifluorophenoxy)heptan-3-yl]cyclopentanecarboxamide

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H25F3N2O3
Canonical SMILES: C1CCC(C1)C(=O)NC(CCCCN)C(=O)COC2=C(C=CC(=C2F)F)F
InChI: InChI=1S/C19H25F3N2O3/c20-13-8-9-14(21)18(17(13)22)27-11-16(25)15(7-3-4-10-23)24-19(26)12-5-1-2-6-12/h8-9,12,15H,1-7,10-11,23H2,(H,24,26)/t15-/m0/s1
InChIKey: OLIMBXKACVCIMM-HNNXBMFYSA-N

Cross-matching ID

PubChem CID: 134347893
TTD ID: D58BFC

References

1	ClinicalTrials.gov (NCT03823404) GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease. U.S.National Institutes of Health.